- Research
- Open access
- Published:
Influences of substrate and tissue type on erinacine production and biosynthetic gene expression in Hericium erinaceus
Fungal Biology and Biotechnology volume 12, Article number: 4 (2025)
Abstract
Background
Lion’s mane (Hericium erinaceus) mycelium produces erinacines, a suite of cyathane diterpenoids with established neuroactivities. While H. erinaceus fruit body tissue has its own characteristic secondary metabolites, it generally does not produce detectable amounts of erinacines. Substrate composition influences the erinacine content of H. erinaceus mycelial cultures, similar to production of secondary metabolites in other fungi. This study explored the relationship between biosynthetic gene expression and erinacine content in H. erinaceus, comparing fruit body tissue to mycelial tissue cultured in two liquid media formulations.
Results
In this study, we compared erinacine production in H. erinaceus fruit body to mycelial tissue cultivated in two liquid media formulations (Complex and Minimal) by quantifying mRNA transcript levels of the erinacine biosynthetic genes eriE, eriG, eriI, eriC, eriJ, eriB, and eriM (collectively, eri genes) alongside high performance liquid chromatography (HPLC) evaluation of erinacines Q, P, A, and C. We also predicted coding sequences for these seven eri genes. The Complex media preparation yielded mycelium with significantly higher erinacine C content, while the Minimal media yielded mycelium with greater erinacine Q content, suggesting an alteration of the biosynthetic pathway related to differences in substrate composition. Despite evident differences in erinacine concentrations, mycelial eri gene transcript levels did not differ significantly between the two liquid media preparations. When evaluated by gene expression or compound concentration, erinacine biosynthesis was substantially greater in mycelia compared to fruit body tissue in H. erinaceus.
Conclusions
Alongside the absence of detectable erinacines within fruit body samples, eri gene transcripts were consistently downregulated in the fruit body compared to the mycelium, particularly at early stages of the biosynthetic pathway. Substrate composition is a critical factor in production of erinacines by H. erinaceus, and large differences in mycelial erinacine content can occur without significant differences in expression of eri genes. Our data support the hypothesis that production of fungal secondary metabolites can be influenced by tissue type and substrate components, and that the expression of eri genes is enriched in the mycelium when compared to the fruit body.
Background
Lion’s mane, H. erinaceus, is a fungus valued for its gourmet edible fruit bodies and medicinal benefits. A wide variety of secondary metabolites have been identified in H. erinaceus and related species that are associated with myriad bioactivities, ranging from antimicrobial effects to neurogenesis/neuritogenesis [1,2,3]. H. erinaceus preparations have been clinically evaluated for the treatment of depression and anxiety symptoms [4, 5], improvement of cognitive functions [6], mild cognitive impairment [7], and correlates of Alzheimer’s disease in adults [8]. Compounds with established neuroactivities [3, 9,10,11,12,13,14,15] produced by H. erinaceus include hericenes and hericenones, typically associated with fruit bodies, and cyathane diterpenoids, including erinacines, which are characteristically found in mycelium [16, 17]. Erinacines comprise a diverse suite of compounds biosynthesized in a complex pathway governed by both enzymatic and non-enzymatic reactions. Abbreviating each erinacine as EX (e.g., erinacine A as EA), this biosynthetic pathway begins with production of EQ [18] and proceeds from EP to EB to EC or EA (Fig. 1).
The eri biosynthetic gene cluster was originally identified as eleven coding sequences localized within 20 kb of a geranylgeranyl diphosphate synthase (GGPPS) gene (Her1A5912/eriE, see Additional file 1), designated eriA through eriJ [19, 20]. This consisted of two UbiA prenyltransferases (eriF and eriG), a UDP-glycosyltransferase (eriJ), three cytochrome P450 proteins (eriA, eriC, and eriI), two NAD(P) oxidoreductases (eriB and eriH), and one ATP-binding cassette transporter (eriD) [20]. Additional genes in the eri cluster have since been characterized [21, 22], including three FAD oxidoreductases (eriK, eriM and eriN), an acetyltransferase (eriL), and two more NAD(P) oxidoreductases (eriO and eriP). While many cyathane diterpenoid compounds and biosynthetic genes have been identified, little is known about the relationship between expression of these genes and erinacine production, particularly in the context of different substrates and types of fungal tissue.
In this study, we explored the impact of liquid media formulations on the expression of genes in the erinacine biosynthetic gene cluster and erinacine content in H. erinaceus mycelium and fruit body tissue. We sequenced and characterized the seven eri genes highlighted in this study, then used RT-qPCR to quantify eriE, eriG, eriI, eriC, eriJ, eriB, and eriM mRNA transcripts in H. erinaceus mycelium grown in two liquid culture media formulations and fruit body samples grown on a supplemented alder sawdust substrate. After HPLC mass spectrometry (HPLC–MS) was employed to identify EQ, EP, EA and EC, we quantified EC and evaluated levels of EQ, EP, and EA with HPLC diode array detection (HPLC–DAD).
Materials and methods
Sequencing and protein predictions
Sanger sequencing for all genes was performed using the Eurofins Genomics, LLC Tube Sequencing service with PCR products amplified from H. erinaceus genomic DNA (gDNA) extracted with a New England BioLabs Monarch Genomic DNA purification kit. Sequencing primers are listed in Additional file 2. With the exception of eriM sequencing primers [22], sequencing primers were custom designed with the aid of NCBI’s Primer Blast (https://www.ncbi.nlm.nih.gov/tools/primer-blast/), accounting for primer length, GC content, and Tm.
Coding sequences were created by aligning gDNA reads with available GenBank eri gene coding sequences to determine intron/exon junctions. In the case of eriM, the sole gene under investigation without a coding sequence available, the eriM gDNA sequence was aligned with H. erinaceus transcriptome shotgun assembly GHOV00000000.1 to determine intron–exon junctions and the subsequent coding sequence (PQ561599.1). Resulting protein sequences were scanned for conserved domains and motifs using the NCBI Conserved Domains tool (https://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi), Swiss Institute of Bioinformatics (SIB) MyHits (https://myhits.sib.swiss/cgi-bin/motif_scan), Rapid UBIquitination detection (RUBI) (http://old.protein.bio.unipd.it/rubi/), and manual searches. Specific amino acid locations for all predicted protein features are included in Additional file 3. Predictions of key domains (Fig. 2, Additional file 3) were made using the NCBI Conserved Domains tool set to an E value threshold of 0.01, and ubiquitinated lysine predictions provided by RUBI were set to a 99% confidence level. SIB MyHits collects the predictions of several different tools which all have their own methods of evaluation of likelihood; therefore, only the most confident putative motifs (rated as either a strong match, ‘!’, or a strong match for a family-specific motif, ‘!!’) were reported.
Summary of erinacine biosynthetic enzymes (Additional file 3). Amino acid lengths of each protein are included at the C-termini with predicted conserved domains and motifs represented by boxes along the length of the sequence
Liquid culture
A mycelial culture of H. erinaceus (genetically identified using standard fungal barcoding regions) was sourced from a private culture library and incubated on agar media (40 g/L barley malt extract, 27 g/L agar, 2 g/L yeast extract) in Petri dishes at room temperature for 25 days. To produce a seed culture, three fully colonized agar wedges (approximately 0.5 cm2 each) were aseptically transferred from a single plate’s leading edge to inoculate 2 L sterile liquid broth (40 g/L barley malt extract, 2 g/L yeast, 1 g/L CaSO4) in a 2.8L Erlenmeyer flask, then stirred at 150 rpm at room temperature and incubated for 21 days. For each liquid culture, 250 mL of broth was prepared in a 500 mL Erlenmeyer flask, with n = 3 Minimal media flasks and n = 3 Complex media flasks. Minimal media was composed of 12 g/L barley malt extract, 0.66 g/L NH4NO3, and 1 g/L CaSO4, suspended in reverse osmosis filtered residential water. Complex media, modified from a previous recipe [23], was composed of 12 g/L dextrose, 5 g/L oatmeal, 1.5 g/L CaCO3, 0.5 g/L (NH₄)₂SO₄, and 0.5 g/L lactalbumin enzymatic hydrolysate. CaSO4 was ground by mortar and pestle, while oatmeal was homogenized using a handheld coffee grinder and sieved through a Hogentogler & Co., Inc. U.S.A. Standard (ASTM E-11) #20 850 μm test sieve prior to addition to liquid culture flasks. Due to their relative insolubility, CaSO4 and oatmeal were weighed and added to each flask separately. Flasks were pressure sterilized at 15 psi for 60 min, and inoculated with 100 mL of seed culture each before incubating in a lidded shaking water bath incubator set to 24 °C and 150 rpm for 21 days.
Fruit body cultivation and sample preparation
H. erinaceus fruit bodies were cultivated on supplemented alder wood sawdust and harvested from colonized blocks. To avoid superficial contaminants, tissue samples were collected for RNA extraction by splitting each fruit body and sampling twice from the center with a sterile scalpel, then immediately flash frozen in epitubes in liquid nitrogen (n = 6). Tissue was stored at −80 °C until RNA extraction. Remaining fruit body tissue was lyophilized at −105 °C and continuous vacuum approaching 0.001 mBar in a Labconco FreeZone 4.5L lyophilizer equipped with an Edwards nXDS 10i dry scroll pump until wholly dried, then homogenized with a Magic Bullet® blender into a fine powder and extracted for HPLC analysis.
Liquid culture mycelial sample preparation
After a 21 day incubation period, liquid culture tissue was harvested in front of a laminar flow hood. Fungal tissue for RNA extraction was obtained from liquid culture flasks using sterile forceps, immediately flash frozen in epitubes in liquid nitrogen, and stored at −80 °C. The remaining H. erinaceus mycelial biomass from each flask was filtered through cheesecloth to separate tissue from liquid media. The resulting biomass from each flask was rinsed with 18.2 MΩ DI water, manually compressed in cheesecloth to remove excess filtrate, then stored in a 50 mL centrifuge tube at −80 °C. Samples were lyophilized in bulk with a collection temperature of −105 °C and under continuous vacuum to 0.001 mBar as described previously. After lyophilization, samples were ground with a mortar and pestle into a fine powder and sampled for HPLC analysis.
RNA extraction and cDNA synthesis
RNA extraction was performed for each frozen sample separately using a Qiagen RNeasy Plant Mini Kit with an RLT lysis buffer; tissue was first frozen in liquid nitrogen and then homogenized using a pestle in pre-cooled 1.5 mL epitubes. Each RNA stock underwent a DNase I (ThermoFisher, RNase-free, Catalog # EN0521) treatment, which used 4.5 μL of DNase I for every 30 μL of RNA and 30 min of incubation at 37 °C, followed by the addition of 3 μL EDTA and 10 min of incubation at 65 °C to terminate the reaction. The RNA stocks were then reverse transcribed into cDNA using an Applied Biosystems High-Capacity cDNA Reverse Transcription Kit. RNA and cDNA stocks were stored at −80 °C. All RNA stock 260/280 ratios were ≥ 2.0, and all original and diluted cDNA stock 260/280 ratios were ≥ 1.8, as assessed using an Agilent Synergy HTX multimode plate reader. For RT-qPCR, stock solutions of each cDNA sample were created at 100 ng/μL concentrations.
RT-qPCR and calculations
RT-qPCR primer sequences (Additional file 4) were either reproduced [20, 24] or designed originally (eriE, eriB, and eriM). RT-qPCR was performed with a Rotor-Gene Q system (Qiagen) and used a QuantiNova SYBR Green PCR kit for all reactions. Each reaction used 10 μL of 2X QuantiNova SYBR Green PCR Master Mix, 2 μL of 10 μM forward primer, 2 μL of 10 μM reverse primer, 2 μL of template cDNA at 100 ng/μL, and RNase-free water to 20 μL. Thermocycling conditions were 5 min at 95 °C, then 50 cycles of 5 s at 95 °C, and 10 s at 60 °C. Specificity of PCR products were confirmed using gel electrophoresis; images of gel checks are included as Additional file 5. All RT-qPCR primer pairs amplified bands of the appropriate size in all sample sets, except for the eriI primers [20] in fruit body tissue, which also amplified a smaller band below the expected 207 bp band. This issue did not reappear within mycelial tissue checks for these primers, suggesting limited primer specificity amid the low levels of eriI mRNA transcript present in fruit body tissue. Actual eriI transcript expression (Cq) values gathered from this fruit body material were comparable to Cq values for other primer pairs (Fig. 3A).
A Average Cq values of all eri gene primers (n = 4 technical replicates) for mycelia cultured in Minimal media (M) or Complex media (C), as well as fruit body tissue (FB). B Fold change in eri gene transcript expression relative to 18S determined by RT-qPCR (n = 3 technical replicates). Results are normalized relative to fruiting body samples. Expression data are represented on a log2 transformed y-axis, with error bars representing the standard deviation of each treatment average
Three bioreplicates were prepared for each treatment group: Minimal media, Complex media, and fruit body tissue. The two samples taken from each fruit body mass (total n = 6) were evaluated separately during gel electrophoresis specificity checks and RT-qPCR transcript quantification, and then combined into single bioreplicates (total n = 3) while calculating average Cq values. Average Cq values were calculated using n = 4 technical replicates for eri gene primers and n = 2 for 18S primers. Fold changes in expression were calculated directly from these averages based on the 2−ΔΔCt method [25], using the total fruit body average Cq (Qiagen’s Ct equivalent) as the calibrator sample and 18S as the reference gene. All statistical comparisons were performed using an unequal variance one-tailed t test, with p ≤ 0.05 considered significant.
Two different 18S RT-qPCR primer pairs, one large subunit (LSU) ribosomal DNA primer pair, and one β-tubulin primer pair were evaluated to identify an optimal reference gene for this sample set by comparing mean Cq (n = 2 technical replicates) for all four primer pairs across all three sample sets, determining each sample’s variation from their treatment average Cq value. The 18S primer pair included in Additional file 4 (and used for all reported Cq values and fold change calculations) was selected because it demonstrated the lowest level of variation across all three sample sets, determined by summing the absolute value of all sample variations for each primer pair and selecting the primer pair with the lowest total sum.
HPLC sample preparation
Extractions were carried out by combining 250 mg of powdered and lyophilized fungal biomass with 10 mL of a 1:3 solution of MeOH:EtOAc in centrifuge tubes, followed by sonication for 5 min and agitation on a plate vortexer for 30 min. After extraction, each sample was centrifuged for 10 min at 2000 rpm. The supernatant was decanted into a scintillation vial and reduced to residue under pressure with a Buchi R-100 rotary evaporator system. The resulting residue was resuspended in 1 mL of methanol and filtered through a 0.22 µm polypropylene syringe filter prior to analysis by HPLC.
HPLC–MS and HPLC–DAD analysis
HPLC–MS analyses were carried out by EZ Labs, LLC (San Diego, CA, USA) on an Agilent 1290/1100 series HPLC equipped with an Agilent 6130 series single quadrupole MS detector and UV/PDA detector. HPLC–DAD was performed on an Agilent 1260 Infinity II chromatography system using a diode array detector. Primary detection of analytes (EA, EC, EP, and EQ) was at 195, 210, and 345 nm. EC was quantified at a wavelength of 195 nm against an analytical standard originating from material purified by EZ Labs, LLC. A gradient method was employed to achieve separations via an Agilent Poroshell 120 EC-C18 2.7 µm 150 mm × 4.6 mm column. Ultrapure 18.2 MΩ deionized water and HPLC grade acetonitrile were used as A and B components of the mobile phase respectively. The gradient in the method was applied as shown in Table 1. The flow rate was set to 1 mL/min, and column temperature was set to 35 °C.
Results
Sequencing and in silico modeling of erinacine biosynthetic genes
Our study selected eriE, eriG, eriI, eriC, eriJ, eriB, and eriM for Sanger sequencing and protein domain prediction prior to an evaluation of mRNA transcript levels. Previously, only six out of seven coding sequences for the eri genes selected in this study were publicly available; we predicted the eriM coding sequence by aligning its sequenced gDNA region with H. erinaceus transcriptome shotgun assembly GHOV00000000.1 to determine intron–exon junctions and obtain a coding sequence (PQ561599.1). Figure 2 summarizes all predicted protein domains and motifs, while more comprehensive results (including tools and confidence levels used) are included as Additional file 3.
RT-qPCR analysis of eri gene mRNA transcripts
After performing an RT-qPCR evaluation of fruit body tissue and mycelia grown in either Minimal media or Complex media, we compared mean Cq values alongside fold changes relative to the housekeeping gene 18S. When examining Cq values directly, we found no statistically significant differences in expression of eri mRNA transcripts between mycelial tissue cultivated in either liquid medium; however, in all 14 comparisons, eri genes were expressed significantly higher in mycelium compared to fruit body tissue (p ≤ 0.05; Fig. 3A). Overall, the lowest expression levels (highest Cq values) were observed for eriG, eriC, and eriE in fruit body tissue, and the highest expression levels (lowest Cq values) were observed for eriE and eriC in mycelia cultured in Minimal and Complex media.
Next, we transformed Cq values into fold changes in expression of eri mRNA transcripts by normalizing and reporting all fold changes relative to the fruit body sample set, which had the lowest mean expression for all transcripts (Fig. 3A). Overall, trends in fold changes between treatments and tissue types were highly similar to those observed for unadjusted Cq values. We observed statistically significant differences between fold change values for all seven tested eri genes when comparing Complex media mycelium to fruit body (p ≤ 0.05), and for three out of seven eri genes when comparing Minimal media mycelium to fruit body (eriG, eriB, and eriM, p ≤ 0.05). No statistical difference was observed between Complex media and Minimal media mycelia when comparing fold change values for any of the seven genes examined (Fig. 3B).
Erinacine production results determined by HPLC–DAD
A combination of HPLC–DAD and HPLC–MS analyses confirmed the identities of EQ, EP, EA, and EC (Additional file 6). HPLC analysis of mycelia revealed significant variation in EC concentrations, as well as differential production of EQ, EP, and EA, depending on media type (Figs. 4 and 5A–D). EC was detected in mycelium grown in Minimal media, but at concentrations approximately two orders of magnitude lower than concentrations observed in mycelium grown in Complex media (Fig. 5A). Analytical standards of EQ, EP, and EA were unavailable; therefore, these erinacines could not be quantified directly. However, each compound was individually compared across tissue types using the measured peak area per gram of dry mycelial tissue (AUC/g).
Representative HPLC UV–Vis chromatographic results for single replicates of mycelia cultivated in Minimal media (gray) and Complex media (black) at 195 nm (top) and 345 nm (bottom) detection channels. Minimal and Complex media yielded mycelia that differed in the measured signal intensities of EQ (as determined by integrated peak areas per gram of fungal biomass, AUC/g; Fig. 5B) and the quantified concentrations of EC (Fig. 5A). Samples used for this figure are the highest-yielding flasks for each sample set: Minimal media flask 3 and Complex media flask 2
A Mean EC content (mg/g dry tissue) as determined by HPLC (n = 3 technical replicates). Error bars represent standard deviations for each flask (each biological replicate tested in triplicate). B Average signal response (AUC/g) in dry biomass for EQ. C Average signal response (AUC/g) in dry biomass for EP. D Average signal response (AUC/g) in dry biomass for EA
In Minimal media mycelium, a greater diversity of minor erinacines and putative erinacine candidates were observed; EQ displayed the least variation and was present at higher concentrations than in Complex media mycelium (according to relative peak areas). Measured peak areas of EP and EA were statistically indistinguishable between mycelia cultivated in Minimal and Complex media (Fig. 5C, D). In accordance with the higher standard deviations in RT-qPCR results for mycelium grown in Minimal media, signal responses of all erinacines were more variable among replicates in the Minimal media compared to Complex media, evidenced by their relative standard deviations (Fig. 5A–D). Fruit bodies were also evaluated for erinacine content by HPLC, but none of these four erinacines were detected in any fruit body tissue.
Discussion
According to RT-qPCR results, H. erinaceus mycelia demonstrated dramatically higher eriE, eriG and eriC expression compared to eriI, eriJ, eriB, and eriM (Fig. 3B). When evaluating transcript expression patterns, we observed that eriG displayed particularly low expression in fruit body, exhibiting the highest mean Cq values of any gene evaluated in either tissue type in this study (Fig. 3A). This may suggest that H. erinaceus provides more transcriptional regulation at the beginning of the erinacine biosynthetic pathway, which has parallels with GGPP-based pathways in plants such as carotenoid biosynthesis [26]. Although detectable, there are substantially lower levels of eri gene transcripts in the center of fruit body samples compared to mycelial samples; future investigations may be warranted to determine if erinacine biosynthesis could occur in the hymenium. More generally, the significant increase in eri gene expression in the mycelium could indicate a wide-ranging lack of engagement of the erinacine biosynthetic pathway in the fruit body. While this does not preclude the possibility of erinacine biosynthesis in fruit body tissue, when combined with our HPLC analyses of these same samples, the low levels of eri gene transcripts in fruit body are consistent with the lack of detectable EQ, EP, EA, or EC.
The few prior studies performing transcript- and protein-level evaluations of H. erinaceus mycelium and fruit body tissue have produced some results inconsistent with our study, potentially driven by differences in detection methods, strains, substrates, and cultivation parameters, as well as time points chosen for sampling. For instance, transcriptome analysis found that eriA and eriC were upregulated in the fruit body compared to mycelium [19], and a proteomic comparison noted that EriB and EriJ were upregulated in fruit body tissue compared to mycelium [24]. However, these studies both used potato dextrose agar (PDA) media, and their results are also inconsistent with many other studies that have predominantly observed erinacine biosynthesis and presence in mycelium [8, 16, 17, 20, 23, 27], with limited possible exception [28]. Given the well-known influence of substrate composition on the secondary metabolic profile of fungi [29], it is possible that PDA media is not ideal for promoting biosynthesis of erinacines.
In a time-series investigation using a liquid media substrate containing barley malt extract and oatmeal similar to the Complex media used in this study, expression of eriF, eriG, eriA, eriC, eriI, and eriJ transcripts generally increased until 10 days post inoculation (dpi), with maximum transcript levels concurrent with detection of EP [20]. Our RT-qPCR results at 21 dpi do not align with the elevated levels of eriC and eriJ noted at 10 dpi by other researchers; in particular, we observed much lower eriJ fold change values. Besides timing, another potential source of discrepancy is that this group used β-tubulin for normalization of fold change values, while our investigation found 18S to be less variable in this context. Few studies have investigated precisely when H. erinaceus mycelium begins producing erinacines, but EC has been detected as early as 3 dpi and as late as 24 dpi in media similar to Complex media, with maximum mycelial EC content largely plateauing from approximately 6–24 dpi [23]. Additionally, EP has been detected in liquid cultured mycelium as early as 5 dpi [20]. Therefore, substrate and incubation time both have demonstrated potential to influence erinacine production dynamics and have led to varied results. Given that maximum EC content was previously observed to remain steady after 6 dpi [23], liquid-cultured H. erinaceus mycelium may have already produced the maximum amount of erinacines possible by 21 dpi, potentially influencing this discrepancy in transcript expression.
Notably, comparisons of both mean Cq and fold changes revealed no statistically significant differences in mRNA transcript levels of any examined eri gene when comparing Minimal media mycelium to Complex media mycelium. These RT-qPCR results contrast the distinctly different erinacine production patterns observed. Mycelia grown in each media preparation exhibited comparable amounts of EP and EA, but Minimal media mycelia yielded significantly more EQ than Complex media mycelia, and Complex media mycelia vastly more EC than Minimal media mycelia (Fig. 5A–D), suggesting that production of EC in Complex media mycelia may have been favored over other evaluated precursors in the biosynthetic pathway (Fig. 1). One potential reason for this division in erinacine production is the different media formulations. For example, the enhanced production of EC by mycelium grown in Complex media aligns with past observations that increasing the complexity of substrate nitrogen sources can promote production of EC [23]. Similarly, Minimal media includes calcium sulfate dihydrate, while Complex media contains calcium carbonate, which has also been noted as vital to production of EC [23]. Clearly, the nutritional composition of liquid media can have a major effect on the production of secondary metabolites in fungal tissue without necessarily affecting enzyme transcript levels.
Given that the increase in EQ levels within Minimal media mycelium is seemingly at the expense of EC, we hypothesize that the erinacine pathway either continues to progress toward production of EC or is largely stalled at preceding erinacines when challenged by nutrient deficiency. Considering their roles in the biosynthetic pathway (Fig. 1), EriL, EriJ, EriB, and EriM are all potential points of enzymatic influence over the secondary metabolite profile of H. erinaceus. Furthermore, the overall lack of correlation between levels of eri gene transcripts and erinacine content suggests this pathway could also be regulated through post-translational mechanisms. These observations highlight the need for in-depth chemical, enzymatic, and transcript-level time-series studies of erinacine biosynthesis to pursue directed production of specific erinacines within H. erinaceus.
Conclusion
Liquid media composition influences erinacine production by H. erinaceus mycelium and may be employed to promote production of specific erinacines. While RT-qPCR evaluation of eriE, eriG, eriI, eriC, eriJ, eriB, and eriM mRNA transcripts demonstrated strong correlation with patterns of erinacine production in the mycelium compared to the fruit body, they were less predictive of concentrations of specific erinacines in H. erinaceus mycelium. Fruit body tissue demonstrated no measurable erinacine content or upregulation of eri mRNA transcript levels alongside a notable downregulation of eriG, the first committed step of erinacine biosynthesis. To our knowledge, this is the first study to compare the influence of substrate on the production of a suite of erinacines and biosynthetic enzyme transcripts in parallel, and the first to concurrently quantify the difference in production of EC between the mycelium and fruit body. This study highlights the potential for significantly influencing the secondary metabolite profile of a fungus through a change in growth substrate, emphasizing the need for more comprehensive analyses across erinacines produced in response to liquid media formulations. Overall, these results demonstrate that substrate composition can impact production of erinacines in H. erinaceus mycelium without significant differences in biosynthetic gene expression, and confirm that several erinacines are abundant in mycelium when compared to fruit body tissue.
Availability of data and materials
The newly available erinacine biosynthetic gene coding sequence is publicly available in the National Institute of Health's database, Genbank, with the accession number PQ561599.1. Raw data for the HPLC data presented in Fig. 5 and Fig. 6 are provided in Additional file 6. All data are available on reasonable request to chase.b@fungi.com.
References
Tang H-Y, Yin X, Zhang C-C, Jia Q, Gao J-M. Structure diversity, synthesis, and biological activity of cyathane diterpenoids in higher Fungi. Curr Med Chem. 2015;22(19):2375–91. https://doiorg.publicaciones.saludcastillayleon.es/10.2174/0929867322666150521091333.
Kobayashi S. Total synthesis of geranyl-resorcinols isolated from mushrooms of genus Hericium. Synthesis. 2023;55(03):417–32. https://doiorg.publicaciones.saludcastillayleon.es/10.1055/a-1944-9623.
Qi J, Wu J, Kang S, Gao J, Kawagishi H, Liu H, Liu C. The chemical structures, biosynthesis, and biological activities of secondary metabolites from the culinary-medicinal mushrooms of the genus Hericium: a review. Chin J Nat Med. 2024;22(7):1–23. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/S1875-5364(24)60590-X.
Nagano M, Shimizu K, Kondo R, Hayashi C, Sato D, Kitagawa K, Ohnuki K. Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake. Biomed Res. 2010;31(4):231–7. https://doiorg.publicaciones.saludcastillayleon.es/10.2220/biomedres.31.231.
Vigna L, Morelli F, Agnelli GM, Napolitano F, Ratto D, Occhinegro A, Di Iorio C, Savino E, Girometta C, Brandalise F, Rossi P. Hericium erinaceus improves mood and sleep disorders in patients affected by overweight or obesity: Could circulating pro-BDNF and BDNF be potential biomarkers? Evidence-Based Complementary Altern Med. 2019. https://doiorg.publicaciones.saludcastillayleon.es/10.1155/2019/7861297.
Saitsu Y, Nishide A, Kikushima K, Shimizu K, Ohnuki K. Improvement of cognitive functions by oral intake of Hericium erinaceus. Biomed Res. 2019;40(4):125–31. https://doiorg.publicaciones.saludcastillayleon.es/10.2220/biomedres.40.125.
Mori K, Inatomi S, Ouchi K, Azumi Y, Tuchida T. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytother Res. 2009;23(3):367–72. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/ptr.2634.
Li I-C, Chang H-H, Lin C-H, Chen W-P, Lu T-H, Lee L-Y, Chen Y-W, Chen Y-P, Chen C-C, Lin DP-C. Prevention of early Alzheimer’s disease by erinacine A-enriched Hericium erinaceus mycelia pilot double-blind placebo-controlled study. Front Aging Neurosci. 2020. https://doiorg.publicaciones.saludcastillayleon.es/10.3389/fnagi.2020.00155.
Kawagishi H, Shimada A, Shirai R, Okamoto K, Ojima F, Sakamoto H, Ishiguro Y, Furukawa S. Erinacines A, B and C, strong stimulators of nerve growth factor (NGF)-synthesis, from the mycelia of Hericium erinaceum. Tetrahedron Lett. 1994;35(10):1569–72. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/S0040-4039(00)76760-8.
Kawagishi H, Shimada A, Shizuki K, Ojima F, Mori H, Okamoto K, Sakamoto H, Furukawa S. Erinacine D, a stimulator of NGF-synthesis, from the mycelia of Hericium erinaceum. Heterocycl Commun. 1996. https://doiorg.publicaciones.saludcastillayleon.es/10.1515/HC.1996.2.1.51.
Kawagishi H, Shimada A, Hosokawa S, Mori H, Sakamoto H, Ishiguro Y, Sakemi S, Bordner J, Kojima N, Furukawa S. Erinacines E, F, and G, stimulators of nerve growth factor (NGF)-synthesis, from the mycelia of Hericium erinaceum. Tetrahedron Lett. 1996;37(41):7399–402. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/0040-4039(96)01687-5.
Saito T, Aoki F, Hirai H, Inagaki T, Matsunaga Y, Sakakibara T, Sakemi S, Suzuki Y, Watanabe S, Suga O, Sujaku T, Smogowicz AA, Truesdell SJ, Wong JW, Nagahisa A, Kojima Y, Kojima N. Erinacine E as a kappa opioid receptor agonist and its new analogs from a basidiomycete, Hericium ramosum. J Antibiot. 1998;51(11):983–90. https://doiorg.publicaciones.saludcastillayleon.es/10.7164/antibiotics.51.983.
Lee EW, Shizuki K, Hosokawa S, Suzuki M, Suganuma H, Inakuma T, Li J, Ohnishi-Kameyama M, Nagata T, Furukawa S, Kawagish H. Two novel diterpenoids, erinacines H and I from the mycelia of Hericium erinaceum. Biosci Biotechnol Biochem. 2000;64(11):2402–5. https://doiorg.publicaciones.saludcastillayleon.es/10.1271/bbb.64.2402.
Mori K, Obara Y, Hirota M, Azumi Y, Kinugasa S, Inatomi S, Nakahata N. Nerve growth factor-inducing activity of Hericium erinaceus in 1321N1 human astrocytoma cells. Biol Pharm Bull. 2008;31(9):1727–32. https://doiorg.publicaciones.saludcastillayleon.es/10.1248/bpb.31.1727.
Phan C-W, Lee G-S, Hong S-L, Wong Y-T, Brkljača R, Urban S, Malek SNA, Sabaratnam V. Hericium erinaceus (Bull.: Fr) Pers. cultivated under tropical conditions: isolation of hericenones and demonstration of NGF-mediated neurite outgrowth in PC12 cells via MEK/ERK and PI3K-Akt signaling pathways. Food Funct. 2014;5(12):3160–9. https://doiorg.publicaciones.saludcastillayleon.es/10.1039/C4FO00452C.
Kawagishi H, Zhuang C. Compounds for dementia from Hericium erinaceum. Drugs Future. 2008;33(2):0149. https://doiorg.publicaciones.saludcastillayleon.es/10.1358/dof.2008.033.02.1173290.
Ma B-J, Shen J-W, Yu H-Y, Ruan Y, Wu T-T, Zhao X. Hericenones and erinacines: stimulators of nerve growth factor (NGF) biosynthesis in Hericium erinaceus. Mycology. 2010;1(2):92–8. https://doiorg.publicaciones.saludcastillayleon.es/10.1080/21501201003735556.
Kenmoku H, Shimai T, Toyomasu T, Kato N, Sassa T. Erinacine Q, a new erinacine from Hericium erinaceum, and its biosynthetic route to erinacine C in the Basidiomycete. Biosci Biotechnol Biochem. 2002;66(3):571–5. https://doiorg.publicaciones.saludcastillayleon.es/10.1271/bbb.66.571.
Chen J, Zeng X, Yang YL, Xing YM, Zhang Q, Li JM, Ma K, Liu HW, Guo SX. Genomic and transcriptomic analyses reveal differential regulation of diverse terpenoid and polyketides secondary metabolites in Hericium erinaceus. Sci Rep. 2017;7(1):1. https://doiorg.publicaciones.saludcastillayleon.es/10.1038/s41598-017-10376-0.
Yang Y, Zhang S, Ma K, Xu Y, Tao Q, Chen Y, Chen J, Guo S, Ren J, Wang W, Tao Y, Yin W-B, Liu H. Discovery and characterization of a new family of diterpene cyclases in bacteria and fungi. Angew Chem Int Ed. 2017;56(17):4749–52. https://doiorg.publicaciones.saludcastillayleon.es/10.1002/anie.201700565.
Liu C, Minami A, Ozaki T, Wu J, Kawagishi H, Maruyama J, Oikawa H. Efficient reconstitution of Basidiomycota diterpene erinacine gene cluster in Ascomycota host Aspergillus oryzae based on genomic DNA sequences. J Am Chem Soc. 2019;141(39):15519–23. https://doiorg.publicaciones.saludcastillayleon.es/10.1021/jacs.9b08935.
Ma K, Zhang Y, Guo C, Yang Y, Han J, Yu B, Yin W, Liu H. Reconstitution of biosynthetic pathway for mushroom-derived cyathane diterpenes in yeast and generation of new “non-natural” analogues. Acta Pharmaceutica Sinica B. 2021;11(9):2945–56. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.apsb.2021.04.014.
Wolters N, Schembecker G, Merz J. Erinacine C: a novel approach to produce the secondary metabolite by submerged cultivation of Hericium erinaceus. Fungal Biol. 2015;119(12):1334–44. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.funbio.2015.10.005.
Zeng X, Ling H, Yang J, Chen J, Guo S. Proteome analysis provides insight into the regulation of bioactive metabolites in Hericium erinaceus. Gene. 2018;666:108–15. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.gene.2018.05.020.
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCt method. Methods. 2001;25(4):402–8. https://doiorg.publicaciones.saludcastillayleon.es/10.1006/meth.2001.1262.
Guo F, Zhou W, Zhang J, Xu Q, Deng X. Effect of the citrus lycopene β-cyclase transgene on carotenoid metabolism in transgenic tomato fruits. PLoS ONE. 2012;7(2):e32221. https://doiorg.publicaciones.saludcastillayleon.es/10.1371/journal.pone.0032221.
Corana F, Cesaroni V, Mannucci B, Baiguera RM, Picco AM, Savino E, Ratto D, Perini C, Kawagishi H, Girometta CE, Rossi P. Array of metabolites in Italian Hericium erinaceus mycelium, primordium, and sporophore. Molecules. 2019;24(19):3511. https://doiorg.publicaciones.saludcastillayleon.es/10.3390/molecules24193511.
Bhandari DR, Shen T, Römpp A, Zorn H, Spengler B. Analysis of cyathane-type diterpenoids from Cyathus striatus and Hericium erinaceus by high-resolution MALDI MS imaging. Anal Bioanal Chem. 2014;406(3):695–704. https://doiorg.publicaciones.saludcastillayleon.es/10.1007/s00216-013-7496-7.
Papagianni M. Fungal morphology and metabolite production in submerged mycelial processes. Biotechnol Adv. 2004;22(3):189–259. https://doiorg.publicaciones.saludcastillayleon.es/10.1016/j.biotechadv.2003.09.005.
Acknowledgements
We thank Bernhard Hellmann for providing crude liquid culture material for EC reference preparation and Matt Renner of EZ Labs, LLC for confirmatory mass spectral analyses of EC material. We extend our appreciation to Travis Zalesky for liquid culture media preparation and inoculation and Alexander Bradshaw for assistance during culturing and extractions, as well as Steve Cividanes, Jerry Angelini, and Jessica Kishiyama for their support in reviewing this manuscript. Finally, we extend our deep gratitude to Paul Stamets whose visionary leadership and support facilitated this project.
Author information
Authors and Affiliations
Contributions
CB and LD designed the project. LD performed the sequencing preparation, PCR, RT-qPCR, and data analysis while CB provided guidance and technical assistance. KM and SM performed the HPLC with support from RN. ZB provided support with media development and data analysis. All authors contributed to writing and editing the manuscript. All authors reviewed and approved the manuscript prior to submission.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
All authors are or have been active in Fungi Perfecti, LLC, a producer of fungal dietary supplements; however, none of the company's products were included in this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Additional file 1.
Nomenclature for the sixteen genes in the broader eri biosynthetic cluster. Identified by Chen et al., Yang et al., and Ma et al.
Additional file 2.
Sanger sequencing primers. Primers marked with an asterisk were reproduced from Ma et al.
Additional file 3.
Summary of locations of select predicted protein domains and motifs in EriE, EriG, EriI, EriC, EriJ, EriB, and EriM
Additional file 4.
RT-qPCR primers. Used to amplify eri gene cDNA sequences for RT-qPCR. Primer sequences marked with * were reproduced from Yang et al., and sequences marked with ** were reproduced from Zeng et al.
Additional file 5.
Gel electrophoresis specificity checks for RT-qPCR primers. See Methods regarding the eriI check in fruit body samples.
Additional file 6.
UV-Vis and mass spectral signatures for erinacines Q, P, A, and C
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Doar, E., Meyer, K.W., Bair, Z.J. et al. Influences of substrate and tissue type on erinacine production and biosynthetic gene expression in Hericium erinaceus. Fungal Biol Biotechnol 12, 4 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s40694-025-00194-9
Received:
Accepted:
Published:
DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s40694-025-00194-9